| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1111/J.1525-1438.2005.00246.X |
| P698 | PubMed publication ID | 16174218 |
| P50 | author | Guillermo Tortolero-Luna | Q63468476 |
| P2093 | author name string | Adler-Storthz K | |
| Scheurer ME | |||
| P2860 | cites work | Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells | Q41532466 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| human papillomavirus infection | Q184627 | ||
| prevention | Q1717246 | ||
| P304 | page(s) | 727-746 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | International Journal of Gynecological Cancer | Q15749181 |
| P1476 | title | Human papillomavirus infection: biology, epidemiology, and prevention | |
| P478 | volume | 15 |
| Q36701607 | A Population-based Study of Invasive Cervical Cancer Patients in Beijing: 1993-2008 |
| Q37234867 | A rare cause of acute urinary retention in women: meatal condyloma accuminata, a case report |
| Q35117953 | Anal warts and anal intradermal neoplasia. |
| Q42221337 | Association of TP53 codon 72 and intron 3 16-bp Ins/Del polymorphisms with cervical cancer risk |
| Q59361060 | Association of antibody to E2 protein of human papillomavirus and p16 with progression of HPV-infected cervical lesions |
| Q44186976 | Bacterial vaginosis as a risk factor for high-grade cervical lesions and cancer in HIV-seropositive women |
| Q37243405 | Benign masses of the female periurethral tissues and anterior vaginal wall |
| Q53661512 | Burden of invasive cervical cancer in North Carolina. |
| Q36473674 | Cellular binding partners of the human papillomavirus E6 protein |
| Q40228937 | Cervical cancer in sub-Saharan Africa: a preventable noncommunicable disease |
| Q90087486 | Cervical cancer stem cells and other leading factors associated with cervical cancer development |
| Q59356924 | Co-infection Of And Human Papilloma Virus In Asymptomatic Sexually Active Individuals |
| Q33286443 | Comprehensive serial analysis of gene expression of the cervical transcriptome |
| Q79703591 | Condylomata acuminata of external urethral meatus causing infravesical obstruction |
| Q45367115 | Correlation between immunocytochemistry of human papilloma virus L1 capsid protein and behavior of low-grade cervical cytology in Korean women |
| Q52622908 | Cytochrome P450 1A1 gene polymorphisms and cervical cancer risk: A systematic review and meta-analysis. |
| Q61453360 | Detection of precancerous lesions in the cervix and HPV infection in women in the region of Maniapure, Bolivar State |
| Q90594835 | Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma |
| Q39327165 | Diversity of HPV types in cancerous and pre-cancerous penile lesions of South African men: implications for future HPV vaccination strategies |
| Q39982787 | Entire genome characterization of human papillomavirus type 16 from infected Thai women with different cytological findings |
| Q34296772 | Epidemiologic modeling of cervical dysplasia with molecular and cytopathological markers |
| Q21284469 | Epidemiology and natural history of human papillomavirus infections in the female genital tract |
| Q36151508 | Evaluation of Association between Vaginal Infections and High-Risk Human Papillomavirus Types in Female Sex Workers in Spain. |
| Q35787592 | Evaluation of results after treatment of cervical intraepithelial lesions by cryotherapy: a preliminary study at the University Hospital Centre in Yaounde: report of 21 cases |
| Q37003947 | Evaluation of the cost of cervical cancer at the National Institute of Oncology, Rabat. |
| Q64921365 | Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review. |
| Q48263482 | Feasibility study of a human papillomavirus E6 and E7 oncoprotein test for the diagnosis of cervical precancer and cancer. |
| Q37697668 | Female urethral condyloma causing bladder outlet obstruction |
| Q36529008 | Functional signatures of protective antiviral T-cell immunity in human virus infections. |
| Q36272771 | GSK3β mediates the carcinogenic effect of HPV16 in cervical cancer |
| Q37309427 | Genetic variants in RAN, DICER and HIWI of microRNA biogenesis genes and risk of cervical carcinoma in a Chinese population |
| Q36389950 | Genital HPV infection and related lesions in men |
| Q37329840 | Gynecologic biopsy for molecular profiling: a review for the interventional radiologist |
| Q37145093 | HPV infection: immunological aspects and their utility in future therapy |
| Q35535495 | HPV16E7-specific siRNA inhibits cell proliferation in CaSki cells |
| Q64359199 | High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N'Djamena, Chad |
| Q36238267 | Human Papillomavirus (HPV) Infection: Molecular Epidemiology, Genotyping, Seroprevalence and Associated Risk Factors among Arab Women in Qatar |
| Q40316397 | Human Papillomavirus Genotypes and Methylation of CADM1, PAX1, MAL and ADCYAP1 Genes in Epithelial Ovarian Cancer Patients |
| Q41923190 | Human Papillomavirus Vaccination Uptake in Canada: A Systematic Review and Meta-analysis |
| Q33409106 | Human Papillomaviruses and genital co-infections in gynaecological outpatients |
| Q37724804 | Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women |
| Q37348056 | Human papillomavirus genotyping and integration in ovarian cancer Saudi patients |
| Q36706422 | Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma |
| Q37363411 | Human papillomavirus--lessons from history and challenges for the future |
| Q54433894 | Human papillomavirus-16 prevalence in gingival tissue and its association with periodontal destruction: a case-control study. |
| Q34291224 | Human papillomaviruses-related cancers. Presence and prevention strategies in the Middle east and north African regions |
| Q41239999 | Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas |
| Q35150650 | Incidence and clinicopathologic behavior of uterine cervical carcinoma in renal transplant recipients |
| Q33924965 | Incidence and progression of cervical lesions in women with HIV: a systematic global review |
| Q37965915 | Inflammation and cancer: a comparative view |
| Q35712531 | Knowledge levels of adolescent girls about human papilloma virus and its vaccine |
| Q37382421 | Knowledge of HPV among United States Hispanic women: opportunities and challenges for cancer prevention |
| Q64124346 | Level and factors associated with uptake of human papillomavirus infection vaccine among female adolescents in Lira District, Uganda |
| Q92838932 | MMP-2 and MMP-9 gene polymorphisms associated with cervical cancer risk |
| Q33755840 | Mechanistic insights into ADXS11-001 human papillomavirus-associated cancer immunotherapy |
| Q52906148 | MicroRNA-195 inhibits proliferation of cervical cancer cells by targeting cyclin D1a. |
| Q36411685 | Molecular profiling of cervical neoplasia. |
| Q24292906 | NF-κB signalling is attenuated by the E7 protein from cutaneous human papillomaviruses |
| Q34576635 | Nothing but skin and bone |
| Q37316158 | Oncogenic activities of human papillomaviruses |
| Q51470014 | Polymorphism of the pre-miR-146a is associated with risk of cervical cancer in a Chinese population. |
| Q57138571 | Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens |
| Q36114517 | Pre-vaccine era cervical human papillomavirus infection among screening population of women in west Austria |
| Q39796733 | Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7. |
| Q42835249 | Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7. |
| Q35547426 | Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma |
| Q33760807 | Prevalence and predictors of high-risk human papillomavirus infection in a population-based sample of women in rural Uganda |
| Q39369170 | Quantifying the impact of dissimilar HPV vaccination uptake among Manitoban school girls by ethnicity using a transmission dynamic model |
| Q37256248 | RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus. |
| Q37306668 | Risk Factors for Urethral Condyloma among Heterosexual Young Male Patients with Condyloma Acuminatum of Penile Skin |
| Q47104647 | The Incidence and Mortality of Cervical Cancer in Ningbo during 2006–2014, China |
| Q33614450 | The full-length isoform of human papillomavirus 16 E6 and its splice variant E6* bind to different sites on the procaspase 8 death effector domain |
| Q51793567 | The male factor in cervical carcinogenesis: a questionnaire study of men's awareness in primary care. |
| Q33908553 | Therapeutic options for treatment of human papillomavirus-associated cancers - novel immunologic vaccines: ADXS11-001. |
| Q55235014 | Unusual and unique distribution of anal high-risk human papillomavirus (HR-HPV) among men who have sex with men living in the Central African Republic. |
| Q33318134 | Up regulation in gene expression of chromatin remodelling factors in cervical intraepithelial neoplasia |
| Q34774880 | Viral carcinogenesis: factors inducing DNA damage and virus integration |
| Q44347146 | Women's awareness of the human papilloma virus and related health problems |
| Q43613013 | p16(INK4a) is superior to high-risk human papillomavirus testing in cervical cytology for the prediction of underlying high-grade dysplasia |
Search more.